340B Advocacy Alliance Bulletin

AHA comments to HRSA on proposed 340B rebate model program; register for Aug. 28 AHA call to discuss rebate model.
The AHA 340B Advocacy Alliance will host a call Aug. 28 at 12:30 p.m. ET to provide insights into the association’s comments to the Health Resources and Services Administration about the agency’s 340B Rebate Model Pilot Program, which will be shared with members next week.
The AHA, joined by several other national groups representing 340B hospitals, today urged the Health Resources and Services Administration to extend the timeline for stakeholder comments, agency consideration, and manufacturer rebate plan submissions for its 340B Rebate Model Pilot Program.
The Health Resources and Services Administration (HRSA) July 31 announced a 340B rebate model pilot program that will provide certain drugmakers the option to effectuate access to 340B discounted pricing for certain drugs under a rebate model.
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug manufacturers to effectuate the 340B ceiling price on select drugs to all 340B covered entities.